Cognitive Memory Enhancement

B84· Mostly solid

Public • 06 Apr 2026

Piracetam & vinpocetine are combined to enhance cognitive function & memory. Piracetam is known for its neuroprotective effects, while vinpocetine improves cerebral blood flow & cognitive performance.

← Back Try alternative layout

Buy stack

Cognitive Memory Enhancement

cognitive memory focus

Piracetam

Daily with food

MODERATE

2400mg

Vinpocetine

Daily with food

MODERATE

10mg

No interactions detected

Each dose includes evidence rationale · doses personalized to your weight

Stack note

Private note on this stack

Track how this stack felt, what you want to change next cycle, or anything you want to save privately in your member zone.

AI risk assessment

Context: No wearable data

PROAI risk assessment is available with Pro.

See plans

Stack pre-check

No personal data connected — connect wearables or upload bloodwork for a personalised check

Clean

Supplements

Training load

Unknown

No flags

No duplication, stimulant, interaction, or recovery concerns detected.

Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.

Interaction Analysis

Pharmacokinetic + pair-level checks

Timing optimizations

Piracetam

Take ~1.5h before the intended effect window

Reaches peak plasma concentration in ~1.5h. Half-life ~5h.

Vinpocetine

Take ~1h before the intended effect window

Reaches peak plasma concentration in ~1h. Half-life ~2h.

Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.

Supplements

2 items

PiracetamModerate

Daily with food •

Provides neuroprotective effects to enhance cognitive function.

Buy ingredient →

2400mg

Cognitive function

Moderate

Population: Adults with cognitive impairment

Study type: Meta-analysis

Dose context: 4800 mg typical (range: 2400–4800 mg)

Meta-analysis showed a positive effect on cognitive dysfunction with a standardized mean difference of 0.439.

Citation: Waegemans et al. (2002). Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Journal of Neurology.•DOI: 10.1016/s0887-8994(97)00153-7

Neuroprotection

Low

Population: General population

Study type: Systematic review

Dose context: 4800 mg typical

Piracetam is included in reviews of neuroprotective strategies, though specific efficacy data is limited.

Citation: Nistor et al. (2017). A Systematic Review of Neuroprotective Strategies during Hypovolemia and Hemorrhagic Shock.•DOI: 10.3390/ijms18112247

Aphasia recovery

Moderate

Population: Post-stroke patients with aphasia

Study type: Systematic review and meta-analysis

Dose context: 4800 mg typical (range: 2400–4800 mg)

Meta-analysis found evidence supporting the use of piracetam for improving aphasia in post-stroke patients.

Citation: Zhang et al. (2016). Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.•DOI: 10.1007/s40263-016-0348-1

VinpocetineLow

Daily with food •

Improves cerebral blood flow & cognitive performance.

Buy ingredient →

10mg

Inflammation

Low

Population: Acute ischemic stroke patients

Study type: RCT

Dose context: 20 mg typical

Vinpocetine inhibits NF-κB-dependent inflammation in stroke patients.

Citation: Zhang et al. (2018). Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients. BMJ.•DOI: 10.1007/s12975-017-0549-z

Neuroprotection

Moderate

Population: Acute ischemic stroke patients

Study type: Systematic review and Meta-analysis

Dose context: 20 mg typical

Vinpocetine was well tolerated but not associated with positive cognitive effects in stroke patients.

Citation: Panda et al. (2022). Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Neurocritical Care.•DOI: 10.1007/s12028-022-01499-y

Higher dosages may be needed to assess efficacy.

Cognitive function

Moderate

Population: Patients with epilepsy

Study type: RCT

Dose context: 20 mg typical (range: 20–20 mg) • Duration: One month

No significant cognitive benefits were observed in patients with epilepsy.

Citation: Meador et al. (2021). Vinpocetine, cognition, and epilepsy. Epilepsy & Behavior.•DOI: 10.1016/j.yebeh.2021.107988

Similar community stacks

Avoid reinventing the wheel: fork a community stack that matches your category tags, then edit it.

Browse all community stacks →

focuscognitivecaffeine-free

Focus Stack (No Stimulants)

by@athlete

Supports focus & mental clarity without stimulants.

L-Theanine

200mg

L-Tyrosine

1000mg

New

View

stresscognitivefocus

Stress Management and Cognitive Support

by@athlete

Combining L-Tyrosine with Eleuthero can reduce stress and support cognitive function. L-Tyrosine is known for its role in stress reduction and cognitive enhancement, while Eleuthero is an adaptogen that supports focus and endurance.

L-Tyrosine

500mg

Eleuthero (Siberian Ginseng)

400mg

New

View

cognitivemoodfocus

Cognitive Enhancement and Mood Support

by@athlete

Combining Noopept with Phenylpiracetam can enhance cognitive function and support mood. Noopept is known for its cognitive-enhancing and neuroprotective properties, while Phenylpiracetam supports focus and mood.

Noopept

10mg

Phenylpiracetam

100mg

New

View